Synapse - Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes

Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes Meeting Abstract

Authors:	Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; Yu, K. H.; Capanu, M.; Kingham, T. P.; D'Angelica, M. I.; Balachandran, V. P.; Jarnagin, W. R.; Wei, A. C.; Soares, K.; Balogun, F.; O'Reilly, E. M.
Abstract Title:	Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
Meeting Title:	2024 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	16 Suppl.
Meeting Dates:	2024 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001275557401138
PROVIDER:	wos
DOI:	10.1200/JCO.2024.42.16_suppl.4170
Notes:	Meeting Abstract: 4170 -- Source: Wos